1 / 2

IL-32 b

janina
Download Presentation

IL-32 b

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Supplementary Figure 2. Effect of IL-32 and siRNA of IL-32 on melanoma, colon and prostate cancer cell growth and apoptosis as well as IL-32 expression. (A), To determine effects of the IL-32 expression level on melanoma, colon and prostate cancer cell growth, the cells were inoculated into 24-well plates (5 × 104 cells/well), and transfected with the IL-32 plasmid (0.1-0.4 g/well) in the absence or presence of siRNA of IL-32b. Cell growth was measured by direct counting after trypan blue staining. Control, untransfected cells. *, p<0.05 compared with the colon and prostate cancer cells transfected with vector.(B), Effect of IL-32 on apoptotic cell death in colon and prostate cancer cell growth. Cells were transfected with the vector or the IL-32 plasmid for 24 h. The apoptotic index was determined as the number of DAPI-stained, TUNEL-positive cells counted. The results are expressed as mean ± SD of three experiments with each experiment performed in triplicate. *, p<0.05 compared with the colon and prostate cancer cells transfected with vector. (C), Expression ofIL-32 was determined with specific antibody of IL-32b as described in material and Methods. The expression band representative of three experiments with each experiment performed in triplicate.

  2. Supp. Fig. 2 SW620 PC3 120 120 100 100 Cell viability (% of control) * * * 80 80 # 60 60 # 40 40 20 20 0 0 50 # 50 # # # 40 40 30 30 A Melanoma 20 * 20 * 10 120 10 0 100 0 * Cell viability (% of control) * 80 # 60 40 20 - - 50 100 - - siCON (nM) - - 50 100 - - 0 siCON (nM) - - 50 100 - - - - - - 50 100 siIL-32 (nM) - - - - 50 100 siIL-32 (nM) - - - - 50 100 B IL-32 (0.4 g/well) IL-32 (0.4 g/well) IL-32 (0.4 g/well) # # Apoptotic rate (%) Apoptotic rate (%) Apoptotic rate (%) * C IL-32b IL-32b IL-32b b-actin b-actin b-actin 5 # 8 # # 4 6 # 5 # # Foldincrease 3 Foldincrease 4 4 * 2 * 2 Foldincrease 3 1 1 * 2 0 0 1 0 siCON (nM) - - 100 - siCON (nM) - - 100 - siCON (nM) - - 100 - siCON (nM) - - 100 - siCON (nM) - - 100 - siCON (nM) - - 100 - siIL-32 (nM) - - - 100 siIL-32 (nM) - - - 100 siIL-32 (nM) - - - 100 siIL-32 (nM) - - - 100 siIL-32 (nM) - - - 100 siIL-32 (nM) - - - 100 IL-32 (0.4 g/well) IL-32 (0.4 g/well) IL-32 (0.4 g/well) IL-32 (0.4 g/well) IL-32 (0.4 g/well) IL-32 (0.4 g/well)

More Related